Reducing TAM recruitment either via depletion of TAM or inhibition of CCL2 has been found to decrease tumour burden in a human melanoma xenograft model.64 Similarly, when neutrophil infiltration was inhibited with CXCR2 inhibition, tumour regression was observed in a lung tumour xenograft model.91 The gene discussed is CCL2; the disease is neoplasm.